The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksODX.L Share News (ODX)

  • There is currently no data for ODX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Bango to offer Microsoft 365; Petrofac prices notes

Mon, 01st Nov 2021 14:35

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

----------

Bango PLC - Cambridge-based mobile commerce company - To offer bundled Microsoft 365 subscriptions, launching with an undisclosed global telecoms provider in the UK. Microsoft 365 combines the full Office suite of Microsoft Office 365 apps with Microsoft Teams collaboration software.

----------

Petrofac Ltd - Jersey-based provider of oilfield services - Reports pricing of its offering of USD600.0 million of 9.75% senior secured notes due 2026 by a newly-formed financing entity, Pyrenees Bondco Ltd. The offering of the temporary notes is subject to customary closing conditions, and settlement is expected to occur on or around Tuesday next week. The issue of the notes is part of a wider refinancing plan comprising the capital raise, a new USD180 million revolving credit facility, a new AED185 million - about USD50 million - bilateral facility and amendment of an existing USD50 million bilateral term loan facility.

----------

Powerhouse Energy Group PLC - Bingley, England-based company which transforms plastics and waste into clean energy - Says its priority remains to ensure its first hydrogen facility becomes fully operational during 2023. Thus, the company and its partner Peel NRE agree extensions to the date of termination rights within the collaboration agreement and exclusivity option end date, both until August 31, 2022. Peel is developing the Protos plant, the first proposed commercial application of Powerhouse's DMG waste plastic to hydrogen technology.

----------

Rockfire Resources PLC - London-based exploration company - Makes progress on its diamond drilling programme currently underway at Copperhead porphyry project in North Queensland, Australia. The company says more than 1,200 veins containing chalcopyrite have been recorded in core from the first three holes. "With each hole drilled, our knowledge of the Copperhead porphyry system is increasing. Structural recordings of copper and molybdenum-bearing veins are providing information and vectors for planned future holes. We will continue to keep the market informed of our ongoing drilling," says CEO David Price.

----------

Helium One Global Ltd - London-based exploration & development company - Starts 2D seismic campaign as part of its phase 2 exploration programme with mobilisation of survey and line clearing crews to its Rukwa project in Tanzania. The campaign is targeting northern extensions of known structural highs that act as a focus for helium charge. "We are excited about our phase 2 programme as we look to build our geological knowledge within the de-risked Rukwa Basin and continue the process of advancing the Rukwa project towards discovery," says CEO David Minchin.

----------

Vaalco Energy Inc - Texas-based hydrocarbon exploration company - Completes two workovers at the Etame field offshore Gabon which adds a total of 1,050 gross barrels of crude oil per day. "We will continue to efficiently operate at Etame which generates strong cash flow to fund our accretive strategic initiatives," says CEO George Maxwell.

----------

Active Energy Group PLC - London-based biomass products producer - Awarded Canadian Patent in respect of the process for beneficiating and cleaning biomass. The Canadian Patent ensures that Active Energy holds the proprietary rights for the CoalSwitch manufacturing process throughout Canada for 20 years from the date of filing, being March 2018.

----------

Downing Strategic Micro-Cap Investment Trust PLC - investment company - Reports net asset value as at August 31 of 93.74 pence, up from 81.16p posted on February 28. Reports share price of 76.00p as at the end of the first half of its current financial year, representing a 19% discount to NAV. "As we look ahead we note that we have some Covid laggards, where share prices have not yet caught up with the improved earnings and operational efficiencies of the underlying businesses. We expect this will ultimately be reflected in valuations – perhaps as we go through the next set of earnings results," says Lead Manager Judith MacKenzie.

----------

Brandshield Systems PLC - Israel-based digital brand protection and online threat hunting services provider - Secures a new business mandate to support an undisclosed international e-commerce platform. The new contract will see the company provide its anti-phishing and impersonation prevention solutions to detect, prevent and shut down fraudulent websites duplicating the client's site.

----------

LoopUp Group PLC - London-based audio & web conferencing product provider - Signs strategic sales & distribution alliance for its Cloud Telephony solution with an undisclosed international telecommunications provider. Under the terms of the deal, the strategic alliance partner will resell LoopUp's Cloud Telephony solution on a white-labelled basis to its business customer base, which spans over 20 country markets. "Both we and the partner see clear customer demand for Microsoft Teams telephony in their markets, and we look forward to working alongside their team to help fulfil that demand," says co-Chief Executive Steve Flavell.

----------

Omega Diagnostics Group PLC - Alva, Scotland-based diagnostic tests company - Agrees with DAM Health Ltd, an in-clinic and mobile test provider, to exclusively supply its Visitech professional use Covid-19 antigen tests to DAM Health's clinics throughout the UK and Europe. Omega has already received an initial purchase order in excess of GBP750,000, it says.

----------

Arecor Therapeutics PLC - Cambridge-based biotechnology company - Signs an exclusive formulation study collaboration with an undisclosed global medical products company. Under the terms of the agreement, Arecor will use its proprietary formulation technology platform, Arestat, to develop a differentiated, stable, liquid drug product, for intravenous administration in two concentrations, that is ready-to-administer. The new liquid formulation of the product supports safe medication practices and operational efficiency by eliminating the need for reconstitution. The partner will fund the development work, the company notes.

----------

Verici Dx PLC - Cardiff, Wales-based clinical diagnostics company - Signs an agreement with the American Society of Transplantation to establish a career development research grant. The grant will be awarded annually to a talented researcher in the fields of transplant science and immunology, enabling them to expand on preliminary research findings that have the potential to further the knowledge base in these areas.

----------

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
1 Jun 2022 19:41

TRADING UPDATES: Indivior, Diurnal start trials; Alien Metals tests

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
30 May 2022 15:59

UK shareholder meetings calendar - next 7 days

Tuesday 31 May 
GYG PLCAGM
JTC PLCAGM
Lookers PLCAGM
McColl's Retail Group PLCAGM
Microlise Group PLCAGM
PageGroup PLCAGM
Petershill Partners PLCAGM
Sportech PLCAGM
Tekcapital PLCAGM
Wednesday 1 June  
Boku IncAGM
Parsley Box Group PLCAGM
One Media IP Group PLCAGM
United Oil & Gas PLCAGM
Flowtech Fluidpower PLCAGM
Dianomi PLCAGM
Honeycomb Investment Trust PLCGM re combination with Pollen Street Capital
East Imperial PLCAGM
Secure Income REIT PLCAGM
Public Policy Holding Co IncAGM
Thursday 2 June  
Clontarf Energy PLCGM re issue of new shares
HealthBeacon PLCAGM
Friday 3 June  
no events scheduled  
Monday 6 June  
Alphawave IP Group PLCAGM
Minoan Group PLCAGM
Omega Diagnostics Group PLCAGM
Sensyne Health PLCGM re strategic financing
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
6 May 2022 12:31

IN BRIEF: Omega raises GBP2.0 million through placing and subscription

Omega Diagnostics Group PLC - Alva, Scotland-based diagnostics company - Raises gross proceeds of GBP2.0 million via a placing of 50.0 million new shares and the issue of 90.0 million warrants at a price of 4.0 pence per share. Plans to use the proceeds to fund its CD4 business to divestment and provide additional working capital. Intends to dispose of the CD4 unit to focus solely on its Health & Nutrition business which contributes to the majority of its revenue. Plans to raise an additional GBP2.0 million by the issue of up to 49.9 million shares through an open offer. Expects its enlarged issued share capital to be 284.7 million shares, assuming full take-up of the open offer shares.

Read more
7 Apr 2022 14:30

IN BRIEF: Omega Diagnostics expects substantial annual revenue growth

Omega Diagnostics Group PLC - Alva, Scotland-based diagnostics company - Expects to report revenue of GBP12.3 million for the year ended March 31, up 41% from GBP8.7 million the year before. Says Covid-19-related revenue grew 53% to GBP2.6 million from GBP1.7 million. Expects ongoing Covid-related income to be minimal. Notes that net cash balance was GBP1.5 million at year-end and that it has an overdraft facility of GBP2.0 million which remains in place and unutilised. Continues to actively explore alternative options to generate additional funds.

Read more
7 Apr 2022 11:06

Omega Diagnostics FY revenues surge, sees 'minimal' ongoing Covid income

(Sharecast News) - Medical diagnostics company Omega said on Thursday that full-year revenues were expected to have surged in 2021 but cautioned that ongoing Covid-related income was now anticipated to be minimal.

Read more
11 Mar 2022 16:10

Omega's professional-use Covid test rejected by UK regulator

(Sharecast News) - Omega Diagnostics announced another disappointment for its Covid-19 tests on Friday, announcing that the UK Health Security Agency said its application for approval of the professional-use 'VISITECT' antigen test under the Coronavirus Test Device Approvals regulations (CTDA) was unsuccessful.

Read more
11 Mar 2022 11:15

AIM WINNERS & LOSERS: Omega Diagnostics Visitect not available in UK

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
7 Mar 2022 21:34

IN BRIEF: Omega completes conditional sale of manufacturing business

Omega Diagnostics Group PLC - Alva, Scotland-based medical diagnostics - Says it has completed the conditional sale agreement for Omega's diagnostic test kit manufacturing business and facility in Alva, Scotland. Agreement is with Accubio Ltd, a wholly-owned subsidiary of Zhejiang Orient Gene Biotech Co Ltd for a cash consideration of GBP1 million.

Read more
1 Mar 2022 20:32

TRADING UPDATES: Hutchmed in Macau boost; UP Global success in Germany

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
11 Feb 2022 14:21

Omega selling Scotland factory after government Covid test plans collapse

(Sharecast News) - Medical diagnostics specialist Omega has signed a conditional sale and purchase agreement with Accubio, a wholly-owned subsidiary of Orient Gene, for the sale of its diagnostic test kit manufacturing business and facility in Alva, Scotland.

Read more
11 Feb 2022 11:31

Omega shares down on discounted fundraise; sells Alva facility

(Alliance News) - Omega Diagnostics Group PLC on Friday announced that it had begun a GBP7.0 million fundraise as well as sold its manufacturing business in Alva, Scotland.

Read more
10 Feb 2022 14:37

IN BRIEF: Omega Diagnostics confirms plan for GBP7 million fundraise

IN BRIEF: Omega Diagnostics confirms plan for GBP7 million fundraise

Read more
3 Feb 2022 15:39

Omega gets CE-marking for Covid-19 test, working on UK approval

(Sharecast News) - Medical diagnostics specialist Omega has successfully CE-marked its 'Visitect' Covid-19 antigen test for self-test use, it announced on Thursday.

Read more
3 Feb 2022 14:35

IN BRIEF: Omega Diagnostics shares up on CE mark for Covid-test

IN BRIEF: Omega Diagnostics shares up on CE mark for Covid-test

Read more
3 Feb 2022 11:00

AIM WINNERS & LOSERS: Omega Covid test gets CE mark; Creo revenue up

AIM WINNERS & LOSERS: Omega Covid test gets CE mark; Creo revenue up

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.